BCL2A1 Gene
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">BCL2A1 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>BCL2A1</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>BFL-1, A1, GRS</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>15q24.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>602</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9GZW8</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>BCL2 family (anti-apoptotic)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low (inducible)</td>
</tr>
<tr>
<td class="label">[Microglia](/cell-types/microglia-neuroinflammation)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Astrocytes](/entities/astrocytes)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Oligodendrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Hematopoietic cells</td>
<td>High</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>
BCL2A1 is a human gene whose product bCL2A1 encodes an anti-apoptotic protein that regulates the intrinsic (mitochondrial) [apoptosis](/entities/apoptosis) pathway:. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
BCL2A1 (BCL2-Related Protein A1) is a gene encoding an anti-apoptotic protein member of the BCL2 family. BCL2A1 plays a critical role in regulating mitochondrial apoptosis pathways, neuronal survival, and neuroinflammation. Dysregulation of BCL2A1 is implicated in Alzheimer's disease, Parkinson's disease, and ALS, making it a key gene in understanding neurodegenerative processes["@bcla2005"][@bcl2008].
Gene Overview
BCL2A1 is located on chromosome 15q24.2 and encodes a mitochondrial anti-apoptotic protein. Unlike other BCL2 family members, BCL2A1 is primarily expressed in hematopoietic cells but is also induced in [neurons](/entities/neurons) under stress conditions[@bcla2010].
Normal Function
BCL2A1 encodes an anti-apoptotic protein that regulates the intrinsic (mitochondrial) apoptosis pathway:
Mitochondrial Outer Membrane Permeabilization (MOMP)
BCL2A1 prevents MOMP by:
- Inhibiting pro-apoptotic BCL2 family proteins (BAX, BAK, BOK)
- Sequestering BH3-only proteins (BIM, BAD, BID)
- Preserving mitochondrial membrane integrity
- Preventing cytochrome c release
Neuronal Survival
In neurons, BCL2A1 protects against:
- Oxidative stress-induced apoptosis
- [Excitotoxicity](/mechanisms/excitotoxicity)
- Mitochondrial dysfunction
- Neurotrophic factor withdrawal
Regulation of Autophagy
BCL2A1 interacts with [autophagy](/entities/autophagy) regulators:
- Modulates Beclin-1 function
- Links apoptosis and autophagy pathways
- Affects protein aggregate clearance
Role in Neurodegenerative Diseases
Alzheimer's Disease
BCL2A1 dysregulation contributes to AD pathogenesis through several mechanisms[@bcl2012][@antiapoptotic2014]:
[Amyloid-beta](/proteins/amyloid-beta) toxicity:
- BCL2A1 expression is altered in AD brains
- May affect neuronal vulnerability to Aβ toxicity
- Interactions with [APP](/entities/app-protein) processing
[Tau](/proteins/tau) pathology:
- Anti-apoptotic function may be overwhelmed in tauopathies
- Relationship between tau and BCL2 family proteins
Neuroinflammation:
- Microglial BCL2A1 affects inflammatory responses
- Cross-talk between apoptosis and neuroinflammation
Parkinson's Disease
In PD, BCL2A1 plays a protective role against dopaminergic neuron loss[@bcl2013][@mitochondrial2015]:
[Alpha-synuclein](/proteins/alpha-synuclein) toxicity:
- BCL2A1 may protect against α-synuclein-induced apoptosis
- Altered expression in substantia nigra
Mitochondrial dysfunction:
- Protects against complex I inhibitors (MPTP, rotenone)
- Maintains mitochondrial integrity in dopaminergic neurons
Oxidative stress:
- Guards against [ROS](/entities/reactive-oxygen-species)-induced neuronal death
- Upregulated in response to oxidative stress
Amyotrophic Lateral Sclerosis (ALS)
BCL2A1 involvement in ALS includes[@bcl2016]:
Motor neuron survival:
- Protects against excitotoxicity
- Modulates SOD1 toxicity
Glial contributions:
- Affects astrocyte-mediated toxicity
- Alters microglial inflammatory responses
Other Neurodegenerative Diseases
- Huntington's Disease: Modified polyglutamine toxicity response
- Frontotemporal Dementia: Altered neuronal stress responses
- Prion Disease: Prion-induced apoptosis modulation
Expression Pattern
BCL2A1 expression in the nervous system:
Expression is inducible in neurons by:
- Oxidative stress
- Cytokine signaling
- Growth factor withdrawal
- DNA damage
Therapeutic Implications
BCL2A1 represents a potential therapeutic target[@targeting2019]:
Small Molecule Activators
- BCL2A1-specific activators under development
- BH3 mimetics targeting BCL2A1
Gene Therapy Approaches
- Viral vector-mediated BCL2A1 overexpression
- CRISPR-based targeting
Combination Strategies
- Combined with other anti-apoptotic proteins
- With neurotrophic factors
Cross-Links
- [BCL2 Gene](/genes/bcl2)
- [Apoptosis Pathway](/mechanisms/apoptosis)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [BCL2 Family Proteins](/proteins/bcl2-family-protein)
See Also
- [ Protein](/proteins/bcl2-family-protein)
- [Apoptosis Pathway](/mechanisms/apoptosis)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [ALS](/diseases/amyotrophic-lateral-sclerosis)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
[Unknown, BCL2A1 in neuronal apoptosis (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15948063/)
[Unknown, BCL2 family and neurodegeneration (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18695338/)
[Unknown, BCL2A1 gene structure and function (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20017189/)
[Unknown, BCL2 proteins in Alzheimer's disease (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22405134/)
[Unknown, Anti-apoptotic strategies in AD (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25163228/)
[Unknown, BCL2 family in Parkinson's disease (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/23628896/)
[Unknown, Mitochondrial apoptosis in PD (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25939512/)
[Unknown, BCL2 proteins in ALS (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27094328/)
[Unknown, Targeting BCL2 family in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31178901/)